$EYPT News Article - EyePoint Pharmaceuticals Announces Positive Topline Data from the Phase 2 DAVIO 2 Trial of EYP-1901 in Wet AMD Achieving All Primary and Secondary Endpoints https://marketwirenews.com/news-releases/eyep...68933.html
(0)
(0)
EyePoint Pharmaceuticals Inc. (EYPT) Stock Research Links